Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST18 antisense RNA 1 (ST18-AS1) is a long noncoding RNA (lncRNA) gene found on the opposite strand of the protein-coding ST18 gene. It is categorized as an ncRNA and is not known to code for protein or to have been characterized as a drug target, receptor, enzyme, transporter, or transcription factor. Detailed biological, disease, or therapeutic relevance has not been established for ST18-AS1 in current literature or major gene/protein databases[3]. Most available information about disease and cellular function centers on the ST18 *protein* (Suppression of Tumorigenicity 18, a transcription factor), not the ST18-AS1 lncRNA itself[1][3]. Note: - There is some risk of confusion with similarly named loci (e.g., STX18-AS1, a different lncRNA[6]); however, ST18-AS1 is a distinct entity[3]. - Most biological, disease, and therapeutic data for "ST18" refer to the protein-coding transcription factor gene, *not* the antisense RNA[1][2]. If you are seeking drug target or biomarker information, consult entries for the ST18 protein/transcription factor rather than ST18-AS1, as the latter is not an established therapeutic target in current research[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ST18 antisense RNA 1 (ST18-AS1).